About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials | 1,621 Studies Recruiting

Clinical TrialsHIV/AIDS

HIV/AIDS Clinical Trials

Browse 1,621 clinical trials for hiv/aids. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1101-1120 of 1,621 trials

Active not recruitingOptimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)People with HIV are at a higher risk of cardiovascular diseases (CVD) due to the effects of the virus and its treatment.NCT06317051·Buenos Aires and 9 others CompletedStudy on Immunopathogenesis in HIV and Hepatitis C CoinfectionLiver-related death is the leading cause of mortality in HIV-infected individuals with CD4+ cell counts over 200, and hepatitis C virus (HCV) infection is the greatest risk for…NCT01296529·Chicago, Illinois and 1 other

Related Searches

aidstrials human immunodeficiencytrials

Data from ClinicalTrials.govTerms

TerminatedCPAP Improving Mortality for Pneumonia in African Children TrialPneumonia mortality rates in African countries like Malawi are high and increased further in children -exposed or infected with human immunodeficiency virus (HIV) as well as those…NCT02484183·Salima

TerminatedEfficacy, Tolerability and Acceptability of Biktarvy by TPLWHThis is a clinical trial for TPLWH (Trans People Living with HIV) who are stable on cART with an undetectable viral load or a detectable viral load but no resistance to NRTIs and…NCT04944654·London

CompletedPeginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)Hepatitis C and HIV infect worldwide millions of people leading to a high rate of coinfected patient with eventually liver cirrhosis and endstage liver disease.NCT00150904·Utrecht, Utrecht

UnknownHIV Medication Adherence in Underserved PopulationsThe purpose of this study is to determine whether cognitive rehabilitation or psychoeducation impacts medication adherence in HIV-1 seropositive individuals.NCT02392884·Los Angeles, California

CompletedPharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected ChildrenThe primary objective of this study is to assess the safety and tolerability of tipranavir (TPV) oral formulation and soft gelatin capsules together with low-dose ritonavir in…NCT00076999·Los Angeles, California and 29 others

CompletedSingle Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023The purpose of this study is to investigate the safety and pharmacokinetics of KM-023 after single/multiple dosing.NCT01348516·Seoul

CompletedA Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related ComplexTo study the tolerance and toxicity of the combination of tumor necrosis factor (TNF) and interferon gamma (IFN-G) or as single agent TNF or IFN-G in HIV infected patients.NCT00001004·Seattle, Washington

WithdrawnPEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.The purpose of the study is to determine the safety, tolerability, and plasma pharmacokinetics (i.e., the levels of TMC589337 and TMC589354 circulating in your blood over time) of…NCT00908414·Utrecht

CompletedClinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in AfricaTherapeutic options to prevent vertical transmission of HIV remain limited.NCT01088516·Lusaka

CompletedA Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSMThe proposed MyPEEPS Mobile intervention is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information specifically developed for…NCT03167606·Birmingham, Alabama and 3 others

CompletedStorytelling Intervention to Promote Cervical Cancer Screening Uptakes Among Malawian Women Living With Human Immunodeficiency VirusTo develop a theory-based culturally-grounded storytelling-based intervention to increase cervical cancer screening among Malawian women living with HIV infection.NCT04307433·Lilongwe

CompletedA Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically SuppressedThis study is designed to assess the antiviral activity and safety of a two-drug regimen of CAB LA + RPV LA compared with maintenance of BIK.NCT04542070·Bakersfield, California and 116 others

CompletedA Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected ParticipantsThis sub-study will assess the pharmacokinetics (PK), safety, tolerability, virologic efficacy and health outcomes of CAB (GSK1265744) and RPV long acting (LA) in HIV-infected…NCT05896761·Bakersfield, California and 31 others

CompletedRelative Bioavailability Study With BMS-955176The purpose of this study is to select the best dose level (amount of drug given) and best formulation of the study drug (BMS-955176) to develop further.NCT02095886·Nottingham

CompletedStudy of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol LevelsThis study is a pilot study examining the effect of extended-release niacin (Niaspan ®) on flow-mediated vasodilation (FMD) of the brachial artery, among human immunodeficiency…NCT00986986·Honolulu, Hawaii

WithdrawnA Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I InfectionThe purpose of this study is to assess the safety and effectiveness of rilpivirine hydrochloride in combination with other anti-retroviral (ARV) medications for the treatment of…NCT01692470

CompletedA Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency VirusEvaluation of the safety and immunogenicity (immunological reactivity) of HIVAC-1e vaccine. An additional goal is to determine which dose level of vaccine might be most effective.NCT00000683·Rochester, New York

Active not recruitingAPPROACH 2.0: HIV, HCV and Syphilis Testing Through PharmaciesHuman Immunodeficiency Virus (HIV), hepatitis C (HCV), and syphilis are sexually transmitted and blood borne infections (STBBI) that affect millions of people worldwide and rates…NCT05534633·St. John's, Newfoundland and Labrador

PreviousPage 56 of 82Next